Pursuing paradigm-shifting opportunities
Our mission is to harness the power of immune science to develop therapies where patient needs and scientific potential converge.
About Nektar
A vision for more impactful medicines
Since its inception, Nektar has led with scientific ingenuity, unwavering resilience and a bold commitment to improving patients’ lives. We have built expertise spanning foundational scientific research, cutting-edge therapeutic discovery, clinical development, strategic partnerships and commercialization – all in pursuit of opportunities to improve outcomes for people with immune-mediated disease.
Through the years, we have developed a proven track record of translating groundbreaking research into innovative therapies in partnership with leading pharmaceutical companies. We remain focused on advancing scientific discoveries into safer, more effective treatments for people living with autoimmune diseases and inflammatory conditions.
Mastering the language of the immune system
At the heart of Nektar’s expertise is a deep understanding of immune system modulation. We leverage the interplay of multiple immune pathways to develop and advance therapies that target the root causes of immune dysfunction. Our approach goes beyond treating symptoms to addressing the fundamental imbalances associated with several immune-mediated diseases.
Our journey has shaped us into the company we are today. Through an understanding of human biology and practical experience, we remain committed to our bold mission of restoring immune health, turning innovative science into transformational care.
Maria Hannaway, MD, Clinical Development
Maria Hannaway, MD, Clinical DevelopmentIt is exciting to join a fast-paced team full of exceptionally intelligent individuals who care about the advancement of science and introducing new and better medications to patients. The mechanism of Nektar’s rezpegaldesleukin is one that should be head-turning for anyone interested in immunology as it is potentially paradigm shifting, and I am thrilled to be a part of such an innovative project with such creative and motivated people.”